Related Experiment Video

Updated: Apr 3, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K

Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations

Wenrui Huang1, Danuta Szczesna-Cordary2

  • 1Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.

Journal of Muscle Research and Cell Motility
|September 20, 2015
PubMed

Insights

Mutations in myosin light chains cause hypertrophic (HCM) and dilated (DCM) cardiomyopathy through distinct mechanisms. RLC mutations alter myosin structure and function, while ELC mutations affect filament interactions, impacting heart muscle contraction.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Genetics of Heart Disease

Background:

  • Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) are significant causes of heart failure.
  • Genetic mutations in sarcomeric proteins are a primary driver of inherited cardiomyopathies.
  • Myosin light chains, including the regulatory light chain (RLC) and essential light chain (ELC), play critical roles in cardiac muscle function.

Purpose of the Study:

  • To elucidate the distinct molecular mechanisms by which specific mutations in RLC and ELC cause HCM and DCM.
  • To investigate the impact of identified RLC and ELC mutations on cardiac myosin structure, function, and filament interactions.
  • To explore the potential of modulating myosin light chain phosphorylation as a therapeutic strategy for cardiomyopathy.

Main Methods:

  • Analysis of four HCM-associated mutations (RLC-A13T, RLC-K104E, ELC-A57G, ELC-M173V) and one DCM-associated mutation (RLC-D94A).
  • Investigating alterations in RLC secondary structure and their effects on the myosin lever arm domain.
  • Examining changes in ELC N-terminus interaction with actin and its impact on thin filament regulation.
  • Assessing the influence of mutations on myosin light chain phosphorylation and exploring exogenous phosphorylation as a therapeutic intervention.

Main Results:

  • RLC mutations induce structural changes in the RLC, affecting the myosin lever arm, cross-bridge cycling rates, and force generation.
  • ELC mutations disrupt the N-terminal interaction with actin, altering cross-talk between thick and thin filaments and modifying the force-pCa relationship.
  • The study highlights differential mechanisms for RLC and ELC mutations in causing distinct cardiomyopathy phenotypes.
  • Exogenous myosin light chain phosphorylation and pseudo-phosphorylation show potential as therapeutic strategies for HCM.

Conclusions:

  • RLC and ELC mutations contribute to cardiomyopathy through divergent molecular pathways.
  • Understanding these distinct mechanisms is crucial for developing targeted therapies for HCM and DCM.
  • Myosin light chain phosphorylation represents a promising avenue for therapeutic intervention in hypertrophy-related cardiac dysfunction.

Keywords:
CardiomyopathyFunctionMutationMyosin light chainsPhosphorylationStructure

More Related Videos

Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers06:53

Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers

Published on: May 4, 2022

2.7K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.3K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
718
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
818
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
769
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
598
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
647
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
830